Current Review Reports是Biomed Central汇集了当今世界上各个学科的著名学者专家，根据当今各个学科的研究现状所撰写的综述性的文章，有一定的时效性和前瞻性。现将其中的高血压相关文章摘录如下，希望可以给各位用户带来一些新的信息。
Angiotensin and Cytoskeletal Proteins-Role in Vascular Remodeling Cellular Phenotypes and the Genetics of Hypertension Endothelin Antagonists and Heart Failure Genetic Determinants of Vascular Reactivity Genetic Targeting of the Renin-Angiotensin System for Long-term Control of Hypertension Genetics of the Mineralocorticoid System in Primary Hypertension Microvascular Angiogenesis and the Renin-Angiotensin System Mild Physical Exercise May Activate the Adenosine-Dopamine System-A New Natriuretic Mechanism Nonhypertensive Cardiac Effects of a High Salt Diet Small Artery Remodeling in Hypertension Trial Report-Pathogenesis of Hypertension Trial Report-Vascular Mechanisms Vasopeptidase Inhibition-Effective Blood Pressure Control for Vascular Protection Interventional Cardiology-Diabetes and Coronary Intervention-Special Considerations for Antithrombotic Therapy Peroxisome Proliferator-activated Receptor and Atherosclerosis Medical Management of Primary Hyperaldosteronism Using Out of Office Blood Pressure Monitoring in the Management of Hypertension Adrenal and the Metabolic Syndrome Adrenomedullin in Hypertension Aldosterone and Vascular Damage Aldosterone-Related Genetic Effects in Hypertension Ambulatory Blood Pressure Monitoring Angiotensin Converting Enzyme Inhibitors-Are They Preferred First-line Therapy Angiotensin, Inflammation, Hypertension, and Cardiovascular Disease Angiotensin-converting Enzyme Inhibitors in Antihypertensive Therapy Antiatherogenic Effects of Antihypertensive Treatment-Trials Completed and Ongoing Antihypertensive Agents-Mechanisms of Drug Action Antihypertensive Agents-Mechanisms of Drug Actions Antihypertensive Agents-Patient Selection and Special Problems Antihypertensive Drug Therapy in the Third Millennium-Are There Benefits Beyond Blood Pressure Antihypertensive Drugs and Reversing of Endothelial Dysfunction in Hypertension Antihypertensive Therapy-Compliance, Quality of Life, and Pharmacoeconomics Antihypertensive Therapy in Pregnancy Antihypertensive Therapy-Patient Selection and Special Problems Antioxidants and Endothelial Dysfunction in Hyperlipidemia Are Sleep-related Breathing Disorders Important Contributing Factors to the Production of Essential Hypertension Atherosclerotic Renal Artery Stenosis-Surgery, Percutaneous Transluminal Angioplasty, or Medical Therapy Barriers to Hypertension Care and Control Calcium Channel Blocker Controversy in Patients with Diabetic Nephropathy-Is There an Issue Cardiovascular Risk and Hypertension Carotid Intima-media Thickness as a Measure of Vascular Target Organ Damage Central Nervous System Norepinephrine Metabolism in Hypertension Central Sympathoinhibitory Effects of Calcium Channel Blockers Cerebral White Matter Lesions in Essential Hypertension Circadian Rhythm of Blood Pressure in Renal Disease Context-dependent Genetic Effects in Hypertension Coronary Heart Disease Prevention As the Primary Goal in Contemporary Trials in the Treatment of Hypertension Cost per Millimeter of Mercury Lowering Is a Measure of Economic Value for Antihypertensive Agents Current Genetics of Essential Hypertension DASH Trials Implicate Dysfunction in Calcium Regulation in the Pathogenesis of Human Hypertension Diagnosis of High Blood Pressure in Children by Means of Ambulatory Blood Pressure Monitoring Diastolic Pressure, Systolic Pressure, or Pulse Pressure Do Most Antihypertensive Agents Have a Sympatholytic Action Doxazosin Arm of the ALLHAT Study Discontinued-How Equal Are Antihypertensive Drugs Effect of Antihypertensive Drugs on Vascular Compliance Effect of Hypertension on Viscoelasticity of Large Arteries in Humans Effects of Antihypertensive Therapy on Hypertensive Vascular Disease Effects of Blood Pressure and Glucose on Endothelial Function Endothelial Dysfunction and Atherosclerosis-Endothelin Receptor Antagonists as Novel Therapeutics Fat Cell Metabolism-Insulin, Fatty Acids, and Renin Free Radical Production and Angiotensin Future of Gene Therapy for Stroke Gene Therapy at the Clinical Horizon Gene Therapy of Hypertensive Vascular Injury Genetic Contributions to Left Ventricular Hypertrophy Genetic Rat Models of Hypertension-Relationship to Human Hypertension Heredity and the Autonomic Nervous System in Human Hypertension How Aggressively Should Blood Pressure Be Treated in Renal Transplant Recipients How Long Should Telomeres Be Hypertension and Current Issues in Compliance and Patient Outcomes Hypertension and Ischemic Nephropathy Hypertension and Metabolic Disarray-Diabetes Mellitus, Insulin Resistance and Obesity Hypertension and Single Nucleotide Polymorphisms Hypertension and the Heart Hypertension in Patients Presenting with Stroke Hypertension in the HIV-Infected Patient Hypertension-induced Organ Damage in African Americans-Transforming Growth Factor-b1 Excess as a Mechanism for Increased Prevalence Hypertension-Kidney, Sodium, and the Renin-Angiotensin System Hyperuricemia and Renal Function Importance of Various Methods of Blood Pressure Measurement in Clinical Trials Improvement of Endothelial Dysfunction as a Surrogate Endpoint in the Treatment of Hypertension Individualized Versus Indiscriminate Therapy for Hypertension Influence of National Guidelines on Antihypertensive Prescribing Patterns Insulin and the Vasculature Interaction Between Leptin and Sympathetic Nervous System in Hypertension Is There a Preferred Antihypertensive Therapy for Isolated Systolic Hypertension and Reduced Arterial Compliance Knockout of Renin-Angiotensin System Genes-Effects on Vascular Development Lessons Learned from Prematurely Terminated Clinical Trials Management of Postural Hypotension Mechanism of Differential Effects of Antihypertensive Agents on Serum Lipids Mental Stress As a Causal Factor in the Development of Hypertension and Cardiovascular Disease Metabolic Syndrome and Related Cardiovascular Risk Methods and Applications of Quality-of-Life Measurement During Antihypertensive Therapy Mouse Models of Blood Pressure Regulation and Hypertension Need to Lower Systolic Blood Pressure New Developments in Mechanisms of Obesity-induced Hypertension-Role of Adipose Tissue New Trends in the Treatment of Orthostatic Hypotension Nighttime Blood Pressure in Elderly Hypertensive Patients Nonesterified Fatty Acids in Blood Pressure Control and Cardiovascular Complications Observational Studies of Antihypertensive Medication Use and Compliance-Is Drug Choice a Factor in Treatment Adherence Optimal Antihypertensive Therapy for Prevention and Treatment of Left Ventricular Hypertrophy Optimal Strategies for Preventing Progression of Renal Disease-Should Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Be Used Together Oxidative Stress and Vascular Damage in Hypertension Pathogenesis of Hypertension-Genetic and Environmental Factors Pathophysiology of Obesity Hypertension Prehypertension-A Possible Target for Antihypertensive Medication Preventing Renal Disease Progression-Is It the Drug or the Blood Pressure Reduction, or Both Primary Aldosteronism-Rare Bird or Common Cause of Secondary Hypertension Problems in the Control of Systolic Blood Pressure Promise of Selective Aldosterone Receptor Antagonists for the Treatment of Hypertension and Congestive Heart Failure Prospective Trials of Angiotensin Receptor Blockers-Beyond Blood Pressure Control Prospectively Designed Overviews of Recent Trials Comparing Antihypertensive Regimens Based on Different Drug Classes Protection from Vascular Risk in Diabetic Hypertension Psychologic Factors as Precursors to Hypertension Racial Differences and the Genetics of Hypertension Recent Advances in the Management of Hypertension in the Elderly Recent Clinical Trial Highlights in Hypertension Recommendations for First-Line Antihypertensive Drugs and Combination Therapies Regulation of Sodium-Potassium ATPase Activity-Impact on Salt Balance and Vascular Contractility Renal Dopamine and Sodium Homeostasis Resistant Hypertension and the Birmingham Hypertension Square Review of Recent Framingham Study Hypertension Research RhoA-Rho-kinase, Vascular Changes, and Hypertension Role of Adhesion Molecules in Vascular Regulation and Damage Role of b2-Adrenergic Receptor Variation in Human Hypertension Role of the Nervous System in Hypertension Role of the Sympathetic Nervous System in Human Renovascular Hypertension Salt and Blood Pressure-What's New Secondary Hypertension-Adrenal and Nervous System Mechanisms Selecting the Right Drug for Initial Antihypertensive Therapy Sex-related Differences in the Insulin Resistance Syndrome Sodium Sensitivity, Not Level of Salt Intake, Predicts Salt Effects Special Situations in the Management of Hypertension Spironolactone in Congestive Heart Failure Statins and Blood Pressure Regulation Strategy for Uncovering Complex Determinants of Hypertension Using Animal Models Studies Examining Risk Reduction in Subjects with Multiple Metabolic and Cardiovascular Risk Factors Syndrome X Following Renal Transplantation Telomeres-The Time Factor in Essential Hypertension The Benefit of Treating Isolated Systolic Hypertension Therapeutic Potential of Endothelin Receptor Antagonists in Cardiovascular Disease Therapeutic Trials Comparing Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers Transgenic and Knockout Mice to Study the Renin-angiotensin System and Other Interacting Vasoactive Pathways Treatment of Hypertension in Diabetes Mellitus Treatment of Hypertension in the Hemodialysis Patient-Beneficial or Not Update-Role of the Angiotensin Type-2 (AT2) Receptor in Blood Pressure Regulation Use of Designer Rats in the Genetic Dissection of Hypertension Use of Gene Markers to Guide Antihypertensive Therapy Use of Single Nucleotide Polymorphisms for Gene Discovery in Hypertension Vascular mechanisms Vasopeptidase Inhibition-A New Direction in Cardiovascular Treatment What Can Knockout Mice Contribute to an Understanding of Hypertension What Is the Optimal Strategy to Intensify Blood Pressure Control and Prevent Progression of Renal Failure Xenobiotics, Dietary Interventions, and Genetically Mediated Therapies
更新于 2002-01-10
